Eptifibatide for Extended Window Ischemic Stroke After Thrombolysis

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2026
This is a multicenter, randomized, open-label, blinded-endpoint clinical trial designed to evaluate the efficacy and safety of early administration of eptifibatide following intravenous thrombolysis in patients with acute ischemic stroke who present 4.5 to 24 hours after symptom onset.
Epistemonikos ID: dbd4df4b00165dfd4eee103f127646ea32423c28
First added on: Jan 17, 2026